Systematix Corporate Services Ltd
- Market Cap ₹ 3,588 Cr.
- Current Price ₹ 276
- High / Low ₹ 276 / 45.6
- Stock P/E 50.5
- Book Value ₹ 13.5
- Dividend Yield 0.04 %
- ROCE 48.4 %
- ROE 42.4 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 79.8% CAGR over last 5 years
- Debtor days have improved from 83.3 to 36.8 days.
Cons
- Stock is trading at 20.5 times its book value
- Earnings include an other income of Rs.28.0 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Finance Industry: Finance & Investments
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
50 | 39 | 37 | 34 | 42 | 54 | 56 | 51 | 55 | 89 | 73 | 146 | 167 | |
32 | 24 | 21 | 22 | 24 | 37 | 41 | 43 | 50 | 63 | 69 | 73 | 99 | |
Operating Profit | 18 | 14 | 16 | 12 | 18 | 17 | 15 | 9 | 5 | 26 | 4 | 73 | 68 |
OPM % | 36% | 37% | 43% | 35% | 43% | 32% | 27% | 17% | 9% | 29% | 6% | 50% | 41% |
1 | 1 | 0 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 5 | 0 | 28 | |
Interest | 14 | 11 | 13 | 12 | 13 | 9 | 13 | 10 | 4 | 3 | 3 | 3 | 4 |
Depreciation | 2 | 2 | 2 | 1 | 1 | 1 | 6 | 6 | 1 | 1 | 1 | 2 | 3 |
Profit before tax | 3 | 3 | 1 | -1 | 6 | 9 | -3 | -5 | 1 | 23 | 6 | 68 | 89 |
Tax % | 33% | 32% | 16% | 56% | 30% | 29% | 12% | -2% | -23% | 25% | 12% | 21% | |
2 | 2 | 1 | -1 | 4 | 6 | -3 | -4 | 1 | 18 | 5 | 53 | 71 | |
EPS in Rs | 0.17 | 0.15 | 0.09 | -0.07 | 0.30 | 0.49 | -0.23 | -0.34 | 0.10 | 1.35 | 0.39 | 4.11 | 5.47 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 7% | 0% | 2% |
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 21% |
3 Years: | 38% |
TTM: | 123% |
Compounded Profit Growth | |
---|---|
10 Years: | 39% |
5 Years: | 80% |
3 Years: | 243% |
TTM: | 515% |
Stock Price CAGR | |
---|---|
10 Years: | 64% |
5 Years: | 136% |
3 Years: | 82% |
1 Year: | 453% |
Return on Equity | |
---|---|
10 Years: | 11% |
5 Years: | 16% |
3 Years: | 25% |
Last Year: | 42% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
Reserves | 37 | 39 | 40 | 39 | 43 | 49 | 67 | 62 | 64 | 82 | 86 | 139 | 162 |
142 | 93 | 149 | 130 | 136 | 155 | 97 | 27 | 36 | 30 | 21 | 21 | 29 | |
53 | 26 | 25 | 25 | 34 | 32 | 27 | 35 | 58 | 101 | 61 | 136 | 112 | |
Total Liabilities | 245 | 171 | 226 | 207 | 226 | 249 | 204 | 138 | 171 | 226 | 181 | 308 | 317 |
11 | 10 | 8 | 7 | 6 | 7 | 12 | 7 | 6 | 6 | 6 | 17 | 15 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 16 | 2 | 2 | 4 | 3 | 5 | 25 | 25 | 41 | 26 |
235 | 161 | 219 | 184 | 218 | 240 | 188 | 127 | 159 | 195 | 150 | 251 | 275 | |
Total Assets | 245 | 171 | 226 | 207 | 226 | 249 | 204 | 138 | 171 | 226 | 181 | 308 | 317 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-10 | 55 | -35 | 55 | -3 | -16 | 49 | 93 | 18 | 51 | -15 | 88 | |
2 | 0 | 2 | 1 | 1 | 1 | 1 | -1 | -2 | -15 | 4 | 24 | |
1 | -61 | 43 | -47 | 8 | 11 | -55 | -83 | 6 | -9 | -14 | -3 | |
Net Cash Flow | -8 | -6 | 10 | 9 | 6 | -5 | -4 | 10 | 22 | 27 | -25 | 108 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 435 | 167 | 173 | 74 | 97 | 111 | 63 | 41 | 68 | 166 | 47 | 37 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 435 | 167 | 173 | 74 | 97 | 111 | 63 | 41 | 68 | 166 | 47 | 37 |
Working Capital Days | 1,106 | 1,029 | 1,529 | 1,173 | 1,106 | 1,093 | 65 | 18 | -17 | -154 | -74 | -183 |
ROCE % | 9% | 8% | 9% | 6% | 10% | 9% | 5% | 4% | 4% | 23% | 7% | 48% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Nov - Submission of en extract of newspaper publication regarding un-audited financial results for the quarter and half year ended September 30, 2024.
-
Announcement under Regulation 30 (LODR)-Allotment
14 Nov - Allotment of 67,35,430 equity shares to non-promoters.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
13 Nov - Systematix reports 83.33% revenue growth in H1 FY25.
-
Results - Financial Results For The Quarter And Half Year Ended September 30, 2024.
13 Nov - Approved un-audited financial results for Q2 2024.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 13, 2024
13 Nov - Approved un-audited financial results for Q2 FY2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Segments